The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation
Abstract
Ewing's family tumors (EFTs) are highly malignant tumors arising from bone and soft tissues that exhibit EWS-FLI1 or variant EWS-ETS gene fusions in more than 85% of the cases. Here we show that CIC, a human homolog of Drosophila capicua which encodes a high mobility group box transcription factor, is fused to a double homeodomain gene DUX4 as a result of a recurrent chromosomal translocation t(4;19)(q35;q13). This translocation was seen in two cases of soft tissue sarcoma diagnosed as Ewing-like sarcoma. CIC-DUX4 exhibits a transforming potential for NIH 3T3 fibroblasts, and as a consequence of fusion with a C-terminal fragment of DUX4, CIC acquires an enhanced transcriptional activity, suggesting that expression of its downstream targets might be deregulated. Gene expression analysis identified the ETS family genes, ERM/ETV5 and ETV1, as potential targets for the gene product of CIC-DUX4. Indeed, CIC-DUX4 directly binds the ERM promoter by recognizing a novel target sequence and significantly up-regulates its expression. This study clarifies the function of CIC and its role in tumorigenesis, as well as the importance of the PEA3 subclass of ETS family proteins in the development of EFTs arising through mechanisms different from those involving EWS-ETS chimeras. Moreover, the study identifies the role of DUX4 that is closely linked to facioscapulohumeral muscular dystrophy in transcriptional regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
Grosschedl, R., Giese, K., & Pagel, J. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90232-1 · Cited by 813
Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., & Turc-Carel, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06137.x · Cited by 539
Deutekom, J. C. T. V., Wljmenga, C., Tlenhoven, E. A. E. V., Gruter, A.-M., Hewitt, J. E., Padberg, G. W., Ommen, G.-J. B. V., Hofker, M. H., & Fronts, R. R. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.12.2037 · Cited by 537
A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon, I. S., Davis, J. N., Braun, B. S., Sublett, J. E., Roussel, M. F., Denny, C. T., & Shapiro, D. N. (1995) · PubMed · Cited by 471
Inappropriate Gene Activation in FSHD
Gabellini, D., Green, M. R., & Tupler, R. (2002) · Cell · doi:10.1016/s0092-8674(02)00826-7 · Cited by 400
A new member of the ETS family fused to EWS in Ewing tumors
Peter, M., Couturier, J., Pacquement, H., Michon, J., Thomas, G., Magdelenat, H., & Delattre, O. (1997) · Oncogene · doi:10.1038/sj.onc.1200933 · Cited by 397
Gabriëls, J., Beckers, M.-C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S. M., Padberg, G. W., Frants, R. R., Hewitt, J. E., Collen, D., et al. (1999) · Gene · doi:10.1016/s0378-1119(99)00267-x · Cited by 353
Hahm, K.-B., Cho, K., Lee, C., Im, Y.-H., Chang, J., Choi, S.-G., Sorensen, P. H. B., Thiele, C. J., & Kim, S.-J. (1999) · Nature Genetics · doi:10.1038/13854 · Cited by 348
Biology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias
Nakamura, T., Largaespada, D. A., Shaughnessy, J. D., Jenkins, N. A., & Copeland, N. G. (1996) · Nature Genetics · doi:10.1038/ng0296-149 · Cited by 303
Self-citationFUS/ERG gene fusions in Ewing's tumors.
Shing, D. C., McMullan, D. J., Roberts, P., Smith, K. K., Chin, S., Nicholson, J. C., Tillman, R. M., Ramani, P., Cullinane, C., & Coleman, N. (2003) · PubMed · Cited by 265
Kaneko, Y., Yoshida, K., Handa, M., Toyoda, Y., Nishihira, H., Tanaka, Y., Sasaki, Y., Ishida, S., Higashino, F., & Fujinaga, K. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<115::aid-gcc6>3.0.co;2-6 · Cited by 239
Jiménez, G., Guichet, A., Ephrussi, A., & Casanova, J. (2000) · Genes & Development · doi:10.1101/gad.14.2.224 · Cited by 232
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00002-5 · Cited by 214
Yang, L., Chansky, H. A., & Hickstein, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005739200 · Cited by 165
Genomic Analysis of Human Chromosome 10q and 4q Telomeres Suggests a Common Origin
van Geel, M., Dickson, M. C., Beck, A. F., Bolland, D. J., Frants, R. R., van der Maarel, S. M., de Jong, P. J., & Hewitt, J. (2002) · Genomics · doi:10.1006/geno.2002.6690 · Cited by 160
Jiang, G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg323 · Cited by 160
Updates on cytogenetics and molecular genetics of bone and soft tissue tumors:
Sandberg, A. A., & Bridge, J. A. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00295-8 · Cited by 147
Identification of p21 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein
Nakatani, F., Tanaka, K., Sakimura, R., Matsumoto, Y., Matsunobu, T., Li, X., Hanada, M., Okada, T., & Iwamoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211470200 · Cited by 137
Nishimori, H., Sasaki, Y., Yoshida, K., Irifune, H., Zembutsu, H., Tanaka, T., Aoyama, T., Hosaka, T., Kawaguchi, S., Wada, T., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206025 · Cited by 109
Nakamura, T., Yamazaki, Y., Saiki, Y., Moriyama, M., Largaespada, D. A., Jenkins, N. A., & Copeland, N. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3178-3186.2000 · Cited by 100
Self-citationHoriuchi, S., Yamamoto, H., Min, Y., Adachi, Y., Itoh, F., & Imai, K. (2003) · The Journal of Pathology · doi:10.1002/path.1387 · Cited by 92
Jenkins, N. A., Copeland, N. G., Taylor, B. A., Bedigian, H. G., & Lee, B. K. (1982) · Journal of Virology · doi:10.1128/jvi.42.2.379-388.1982 · Cited by 82
The PEA3 Group of ETS-related Transcription Factors
de Launoit, Y., Chotteau‐Lelièvre, A., Beaudoin, C., Coutte, L., Netzer, S., Brenner, C., Huvent, I., & Baert, J. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46832-8_13 · Cited by 81
Yamamoto, H. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh011 · Cited by 75
Hahm, K. (1999) · Nature Genetics · doi:10.1038/70611 · Cited by 74
Lee, C.-J., Chan, W.-I., Cheung, M. C. H., Cheng, Y., Appleby, V. J., Orme, A. T., & Scotting, P. J. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00439-4 · Cited by 73
Goff, D. J., Nilson, L. A., & Morisato, D. (2001) · Development · doi:10.1242/dev.128.22.4553 · Cited by 68
Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Ben‐Baruch, G., & Reich, R. (2003) · PubMed · Cited by 42
Induction of tenascin‐C by tumor‐specific EWS‐ETS fusion genes
Watanabe, G., Nishimori, H., Irifune, H., Sasaki, Y., Ishida, S., Zembutsu, H., Tanaka, T., Kawaguchi, S., Wada, T., Hata, J., et al. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10153 · Cited by 41
Identification of target genes for EWS/ATF-1 chimeric transcription factor
Jishage, M., Fujino, T., Yamazaki, Y., Kuroda, H., & Nakamura, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206074 · Cited by 39
Self-citationHuman KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells
Treff, N. R., Dement, G. A., Adair, J. E., Britt, R. L., Nie, R., Shima, J. E., Taylor, W. E., & Reeves, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207926 · Cited by 35
Cited by
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
Bettegowda, C., Agrawal, N., Jiao, Y., Sausen, M., Wood, L. D., Hruban, R. H., Rodriguez, F. J., Cahill, D. P., McLendon, R., Riggins, G., et al. (2011) · Science · doi:10.1126/science.1210557 · Cited by 553
Accurate and efficient detection of gene fusions from RNA sequencing data
Uhrig, S., Ellermann, J., Walther, T., Burkhardt, P., Fröhlich, M., Hutter, B., Toprak, U. H., Neumann, O., Stenzinger, A., Scholl, C., et al. (2021) · Genome Research · doi:10.1101/gr.257246.119 · Cited by 526
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
Pierron, G., Tirode, F., Lucchesi, C., Reynaud, S., Ballet, S., Cohen-Gogo, S., Perrin, V., Coindre, J.-M., & Delattre, O. (2012) · Nature Genetics · doi:10.1038/ng.1107 · Cited by 478
Geng, L. N., Yao, Z., Snider, L., Fong, A. P., Cech, J. N., Young, J. M., van der Maarel, S. M., Ruzzo, W. L., Gentleman, R. C., Tawil, R., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.11.013 · Cited by 458
Metadata
- Authors
- Kawamura-Saito, M., Yamazaki, Y., Kaneko, K., Kawaguchi, N., Kanda, H., Mukai, H., Gotoh, T., Motoi, T., Fukayama, M., Aburatani, H., Takizawa, T., & Nakamura, T.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-22
- Volume
- 15
- Issue
- 13
- Pages
- 2125-2137
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2136522034
- Cited by
- 459
- References
- 36
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.